BriSTAR Immunotech
PrivateLast Round
Series C
Jul 6, 2026
Total Funding Raised
$65.5M
Company Overview
BriSTAR Immunotech is a clinical-stage biotechnology company that develops engineered T-cell immunotherapy products for cancer and autoimmune diseases using its proprietary STAR-T and enTCR-T technology platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BriSTAR Immunotech Comps
Public and private peers based on sector, stage, and business model.
BriSTAR Immunotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 6, 2026 | ||||
| Series B Extension | Jul 18, 2022 | ||||
| Series B | Oct 11, 2021 | ||||
| Series A Extension | Jan 1, 2020 |
BriSTAR Immunotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing Chang Development | Series B |
| Loyal Valley Capital | Series C |
| Shenzhen Sangel Venture Capital | Series B |
| Highlight Capital | Series B |
| Daoyuan Capital | Series B |
| Qifu Capital | Series A, Angel, Pre Seed |
| Hankang Capital | Series A Extension |
BriSTAR Immunotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BriSTAR Immunotech's valuation, stock price, and market status.
